Your browser doesn't support javascript.
loading
Oncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate Tumors.
Annels, Nicola E; Simpson, Guy R; Denyer, Mick; Arif, Mehreen; Coffey, Matt; Melcher, Alan; Harrington, Kevin; Vile, Richard; Pandha, Hardev.
Afiliação
  • Annels NE; Targeted Cancer Therapy, Department of Clinical and Experimental Medicine, Leggett Building, University of Surrey, Guildford, Surrey GU2 7WG, UK.
  • Simpson GR; Targeted Cancer Therapy, Department of Clinical and Experimental Medicine, Leggett Building, University of Surrey, Guildford, Surrey GU2 7WG, UK.
  • Denyer M; Targeted Cancer Therapy, Department of Clinical and Experimental Medicine, Leggett Building, University of Surrey, Guildford, Surrey GU2 7WG, UK.
  • Arif M; Targeted Cancer Therapy, Department of Clinical and Experimental Medicine, Leggett Building, University of Surrey, Guildford, Surrey GU2 7WG, UK.
  • Coffey M; Oncolytics Biotech, Inc., 210, 1167 Kensington Crescent NW Calgary, AB T2N 1X7, Canada.
  • Melcher A; Translational Immunotherapy Team, The Institute of Cancer Research, 237 Fulham Road, London SW6 6JB, UK.
  • Harrington K; Targeted Therapy Team, The Institute of Cancer Research, 237 Fulham Road, London SW6 6JB, UK.
  • Vile R; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
  • Pandha H; Targeted Cancer Therapy, Department of Clinical and Experimental Medicine, Leggett Building, University of Surrey, Guildford, Surrey GU2 7WG, UK.
Mol Ther Oncolytics ; 20: 434-446, 2021 Mar 26.
Article em En | MEDLINE | ID: mdl-33665363
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido